RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Sartorius Stedim Biotech Stock

Sartorius Stedim Biotech ROCE 2024

Sartorius Stedim Biotech ROCE

0.18

Ticker

DIM.PA

ISIN

FR0013154002

WKN

A2AJKS

In 2024, Sartorius Stedim Biotech's return on capital employed (ROCE) was 0.18, a -59.67% increase from the 0.44 ROCE in the previous year.

Sartorius Stedim Biotech Aktienanalyse

What does Sartorius Stedim Biotech do?

Sartorius Stedim Biotech SA is a company specializing in the development, manufacturing, and marketing of products and services for the biopharmaceutical industry. It was formed in 2007 through the merger of two companies, Sartorius and Stedim Biotech, and is headquartered in Aubagne, France. The company has a history dating back to 1870 when Florenz Sartorius, a mechanic, founded a precision scale factory in Göttingen, Germany. Over the years, Sartorius became a leading provider of laboratory scales and equipment worldwide. In 1951, the company was renamed Sartorius AG and expanded into filtration technology. Stedim Biotech, on the other hand, was founded in 1957 as a manufacturer of plastic products and is based in Aubagne, France. It has since become a leading provider of products and services for the biopharmaceutical industry. Today, Sartorius Stedim Biotech SA operates in four business segments: bioprocess systems, laboratory equipment, services, and specialized products. Its bioprocess systems segment includes products and solutions for biopharmaceutical production such as fermenters, bioreactors, cryogenic storage tanks, and filtration systems. The laboratory equipment segment offers a wide range of lab products including scales, pipettes, and analysis devices. The services segment includes consulting, training, and technical services for the biopharmaceutical industry. Lastly, the specialized products segment provides a broad range of products for specific applications, such as disposable syringes for medication administration. Sartorius Stedim Biotech SA has developed a wide range of products for the biopharmaceutical industry, including fermenters and bioreactors for the production of biological drugs, filtration systems for protein purification and cell culture media, disposable syringes for medication administration, and laboratory equipment for sample analysis. The company's business model is to offer a comprehensive range of products and services for the biopharmaceutical industry. It focuses on high-quality and innovative products and services, as well as providing consultation and support to its customers in solving challenges in biopharmaceutical production. Overall, Sartorius Stedim Biotech SA is a leading provider of products and services for the biopharmaceutical industry. Its broad product range and consultancy and support services make it an important partner for the biopharmaceutical industry in the production of biological drugs. Sartorius Stedim Biotech ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROCE Details

Unraveling Sartorius Stedim Biotech's Return on Capital Employed (ROCE)

Sartorius Stedim Biotech's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.

Year-to-Year Comparison

Analyzing Sartorius Stedim Biotech's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.

Impact on Investments

Sartorius Stedim Biotech's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.

Interpreting ROCE Fluctuations

Changes in Sartorius Stedim Biotech’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.

Frequently Asked Questions about Sartorius Stedim Biotech stock

What is the ROCE (Return on Capital Employed) of Sartorius Stedim Biotech this year?

The ROCE of Sartorius Stedim Biotech is 0.18 undefined this year.

How has the ROCE (Return on Capital Employed) of Sartorius Stedim Biotech developed compared to the previous year?

The ROCE of Sartorius Stedim Biotech has increased by -59.67% decreased compared to the previous year.

What does a high ROCE (Return on Capital Employed) mean for investors of Sartorius Stedim Biotech?

A high Return on Capital Employed (ROCE) indicates that Sartorius Stedim Biotech has efficient capital utilization and is able to achieve a higher return on its invested capital. This can be appealing to investors.

What does a low ROCE (Return on Capital Employed) mean for investors of Sartorius Stedim Biotech?

A low ROCE (Return on Capital Employed) can indicate that Sartorius Stedim Biotech has an inefficient utilization of its capital and may have difficulty in achieving a satisfactory return on its invested capital. This can be uncertain or unattractive for investors.

How does an increase in ROCE from Sartorius Stedim Biotech impact the company?

An increase in the ROCE of Sartorius Stedim Biotech can be an indicator of improved company efficiency and show that it is achieving higher profits in relation to its investments.

How does a reduction in the ROCE of Sartorius Stedim Biotech affect the company?

A decrease in ROCE of Sartorius Stedim Biotech can be an indicator of deteriorated efficiency of the company, indicating that it is generating lower profits in relation to its investments.

What are some factors that can influence the ROCE of Sartorius Stedim Biotech?

Some factors that can affect Sartorius Stedim Biotech's ROCE include efficiency in managing assets, profitability of investments, cost efficiency, and market conditions.

Why is the ROCE of Sartorius Stedim Biotech so important for investors?

The ROCE of Sartorius Stedim Biotech is important for investors as it is an indicator of the company's efficiency and shows how successful the company is in relation to its investments. A high ROCE can indicate strong financial performance of the company.

What strategic measures can Sartorius Stedim Biotech take to improve the ROCE?

To improve the ROCE, Sartorius Stedim Biotech can take measures such as increasing efficiency in asset management, optimizing investments, cost savings, and exploring new revenue sources. It is important for the company to conduct a thorough review of its operations to determine the best strategic actions to improve the ROCE.

How much dividend does Sartorius Stedim Biotech pay?

Over the past 12 months, Sartorius Stedim Biotech paid a dividend of 2.88 EUR . This corresponds to a dividend yield of about 1.57 %. For the coming 12 months, Sartorius Stedim Biotech is expected to pay a dividend of 3.69 EUR.

What is the dividend yield of Sartorius Stedim Biotech?

The current dividend yield of Sartorius Stedim Biotech is 1.57 %.

When does Sartorius Stedim Biotech pay dividends?

Sartorius Stedim Biotech pays a quarterly dividend. This is distributed in the months of April, April, April, May.

How secure is the dividend of Sartorius Stedim Biotech?

Sartorius Stedim Biotech paid dividends every year for the past 27 years.

What is the dividend of Sartorius Stedim Biotech?

For the upcoming 12 months, dividends amounting to 3.69 EUR are expected. This corresponds to a dividend yield of 2.01 %.

In which sector is Sartorius Stedim Biotech located?

Sartorius Stedim Biotech is assigned to the 'Health' sector.

Wann musste ich die Aktien von Sartorius Stedim Biotech kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Sartorius Stedim Biotech from 4/4/2024 amounting to 0.69 EUR, you needed to have the stock in your portfolio before the ex-date on 4/2/2024.

When did Sartorius Stedim Biotech pay the last dividend?

The last dividend was paid out on 4/4/2024.

What was the dividend of Sartorius Stedim Biotech in the year 2023?

In the year 2023, Sartorius Stedim Biotech distributed 2.52 EUR as dividends.

In which currency does Sartorius Stedim Biotech pay out the dividend?

The dividends of Sartorius Stedim Biotech are distributed in EUR.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Sartorius Stedim Biotech stock can be added to a savings plan with the following providers: Trade Republic

Andere Kennzahlen von Sartorius Stedim Biotech

Our stock analysis for Sartorius Stedim Biotech Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Sartorius Stedim Biotech Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.